Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Aug 10, 2016 $28.90 $28.90 $28.90 $28.90 26 100
Aug 09, 2016 $31.60 $31.60 $31.60 $31.60 4 370
Aug 08, 2016 $31.60 $31.60 $31.60 $31.60 6 580
Aug 05, 2016 $32.00 $32.00 $32.00 $32.00 3 940
Aug 04, 2016 $30.90 $30.90 $30.90 $30.90 14 620
Aug 03, 2016 $31.60 $31.60 $31.60 $31.60 22 880
Aug 02, 2016 $28.90 $28.90 $28.90 $28.90 13 530
Aug 01, 2016 $27.10 $27.10 $27.10 $27.10 8 390
Jul 29, 2016 $26.20 $26.20 $26.20 $26.20 8 370
Jul 28, 2016 $27.00 $27.00 $27.00 $27.00 5 180
Jul 27, 2016 $26.90 $26.90 $26.90 $26.90 9 810
Jul 26, 2016 $26.30 $26.30 $26.30 $26.30 9 130
Jul 25, 2016 $26.50 $26.50 $26.50 $26.50 11 450
Jul 22, 2016 $28.10 $28.10 $28.10 $28.10 4 820
Jul 21, 2016 $27.90 $27.90 $27.90 $27.90 10 670
Jul 20, 2016 $29.20 $29.20 $29.20 $29.20 9 890
Jul 19, 2016 $25.80 $25.80 $25.80 $25.80 13 840
Jul 18, 2016 $28.50 $28.50 $28.50 $28.50 6 220
Jul 15, 2016 $28.50 $28.50 $28.50 $28.50 5 040
Jul 14, 2016 $27.20 $27.20 $27.20 $27.20 7 060
Jul 13, 2016 $27.90 $27.90 $27.90 $27.90 7 430
Jul 12, 2016 $29.30 $29.30 $29.30 $29.30 14 650
Jul 11, 2016 $28.20 $28.20 $28.20 $28.20 7 220
Jul 08, 2016 $28.80 $28.80 $28.80 $28.80 18 990
Jul 07, 2016 $28.40 $28.40 $28.40 $28.40 11 680
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT